FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

116124008: Monobasic sodium phosphate (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
177097019 Monobasic sodium phosphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
675181017 Monobasic sodium phosphate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2691863012 Sodium acid phosphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
38311000188117 phosphate monosodique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Monobasic sodium phosphate Is a Sodium compound true Inferred relationship Some
Monobasic sodium phosphate Is a Phosphate salt false Inferred relationship Some
Monobasic sodium phosphate Is a Laxative (substance) true Inferred relationship Some
Monobasic sodium phosphate Is a agent acidifiant false Inferred relationship Some
Monobasic sodium phosphate Is a Phosphate true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Sodium acid phosphate 1.72g suppository The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monobasic sodium phosphate Inferred relationship Some
Product containing monobasic sodium phosphate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Monobasic sodium phosphate Inferred relationship Some 1
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monobasic sodium phosphate Inferred relationship Some
Product containing only methenamine mandelate 500 mg and sodium acid phosphate 500 mg/1 each oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monobasic sodium phosphate Inferred relationship Some
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monobasic sodium phosphate Inferred relationship Some
Product containing monobasic sodium phosphate and sodium bicarbonate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Monobasic sodium phosphate Inferred relationship Some 1
Sodium acid phosphate + sodium phosphate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monobasic sodium phosphate Inferred relationship Some
Product containing precisely monobasic sodium phosphate 1.5 gram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monobasic sodium phosphate Inferred relationship Some
Product containing methenamine mandelate and sodium phosphate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monobasic sodium phosphate Inferred relationship Some
Sodium acid phosphate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monobasic sodium phosphate Inferred relationship Some
phosphate monosodique monohydrate Is a False Monobasic sodium phosphate Inferred relationship Some
sodio fosfato monobasico diidrato Is a False Monobasic sodium phosphate Inferred relationship Some
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Monobasic sodium phosphate Inferred relationship Some 2
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Monobasic sodium phosphate Inferred relationship Some 2
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monobasic sodium phosphate Inferred relationship Some 1
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Monobasic sodium phosphate Inferred relationship Some 1
Product containing only methenamine mandelate 500 mg and sodium acid phosphate 500 mg/1 each oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monobasic sodium phosphate Inferred relationship Some 1
Product containing only methenamine mandelate 500 mg and sodium acid phosphate 500 mg/1 each oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Monobasic sodium phosphate Inferred relationship Some 1
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monobasic sodium phosphate Inferred relationship Some 1
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Monobasic sodium phosphate Inferred relationship Some 1
Product containing precisely monobasic sodium phosphate 1.5 gram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monobasic sodium phosphate Inferred relationship Some 1
Product containing precisely monobasic sodium phosphate 1.5 gram/1 each conventional release oral tablet (clinical drug) This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Monobasic sodium phosphate Inferred relationship Some 1
Monobasic sodium phosphate monohydrate (substance) Is a False Monobasic sodium phosphate Inferred relationship Some
Product containing methenamine and monobasic sodium phosphate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Monobasic sodium phosphate Inferred relationship Some 1
Monobasic sodium phosphate monohydrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Monobasic sodium phosphate Inferred relationship Some
phosphate monosodique monohydrate This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. False Monobasic sodium phosphate Inferred relationship Some
sodio fosfato monobasico diidrato This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. False Monobasic sodium phosphate Inferred relationship Some
Product containing precisely monobasic sodium phosphate 1.5 gram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Monobasic sodium phosphate Inferred relationship Some 1
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Monobasic sodium phosphate Inferred relationship Some 2
Monobasic sodium phosphate dodecahydrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Monobasic sodium phosphate Inferred relationship Some
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Monobasic sodium phosphate Inferred relationship Some 2
Monobasic sodium phosphate dihydrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Monobasic sodium phosphate Inferred relationship Some
Monobasic sodium phosphate anhydrous (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Monobasic sodium phosphate Inferred relationship Some
Product containing monobasic sodium phosphate in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Monobasic sodium phosphate Inferred relationship Some 1
Product containing methenamine and monobasic sodium phosphate in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Monobasic sodium phosphate Inferred relationship Some 1
Product containing only monobasic sodium phosphate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Monobasic sodium phosphate Inferred relationship Some 1
Product containing only monobasic sodium phosphate and sodium bicarbonate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Monobasic sodium phosphate Inferred relationship Some 1
Product containing only methenamine and monobasic sodium phosphate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Monobasic sodium phosphate Inferred relationship Some 1
Methenamine and monobasic sodium phosphate only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Monobasic sodium phosphate Inferred relationship Some 1
Monobasic sodium phosphate only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Monobasic sodium phosphate Inferred relationship Some 1
Methenamine mandelate 300 mg and monobasic sodium phosphate 500 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Monobasic sodium phosphate Inferred relationship Some 1
Product containing precisely methenamine mandelate 500 milligram and monobasic sodium phosphate 500 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Monobasic sodium phosphate Inferred relationship Some 1
Dibasic sodium phosphate 240 microgram/mL and monobasic sodium phosphate 542 microgram/mL oral solution The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Monobasic sodium phosphate Inferred relationship Some 1
Dibasic sodium phosphate 240 microgram/mL and monobasic sodium phosphate 542 microgram/mL oral solution This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Monobasic sodium phosphate Inferred relationship Some 1
Dibasic sodium phosphate and monobasic sodium phosphate only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Monobasic sodium phosphate Inferred relationship Some 1
Product containing dibasic sodium phosphate and monobasic sodium phosphate in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Monobasic sodium phosphate Inferred relationship Some 1
Dibasic sodium phosphate and monobasic sodium phosphate only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Monobasic sodium phosphate Inferred relationship Some 1
Dibasic sodium phosphate- and monobasic sodium phosphate-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Monobasic sodium phosphate Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start